HDAC9 and neoplasm: To compare the anticancer efficacy of cisplatin with the pan-HDAC inhibitor SAHA, several tumor fragments (~3 × 3 mm) from GCX-004 (passage 8) were implanted subcutaneously on the flanks of 16 athymic NUDE mice.